Medicare Enrolled
Dr. Michael Jones, M.D.
Optician · Bryan, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jones from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jones?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jones
Dr. Michael Jones is an optician specialist in Bryan, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Jones performed 1,215 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Jones received a total of $18,336 from 66 pharmaceutical and/or device companies across 1066 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jones is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 46% volume in TX
$18,336 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,215
Medicare services
Top 46% in TX for optician
Not available
Unique patients (not deduplicated)
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
445 | $78 | $200 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
113 | $0 | $7 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
111 | $1 | $8 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $114 | $250 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
77 | $124 | $161 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
52 | $28 | $80 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $61 | $95 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
38 | $211 | $438 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
35 | $30 | $35 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
32 | $32 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $47 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
28 | $86 | $140 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
27 | $9 | $35 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
25 | $45 | $120 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $124 | $290 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
24 | $85 | $170 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
16 | $39 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$18,336
Total received (2018-2024)
Avg $2,619/year across 7 years
Top 10% in TX for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,066
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,740
2023
$2,790
2022
$2,939
2021
$2,651
2020
$2,140
2019
$2,336
2018
$2,742
Payments by company (2024)
Novo Nordisk Inc
$485
AstraZeneca Pharmaceuticals LP
$383
ABBVIE INC.
$249
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$181
Otsuka America Pharmaceutical, Inc.
$170
Bayer Healthcare Pharmaceuticals Inc.
$164
Boehringer Ingelheim Pharmaceuticals, Inc.
$142
PFIZER INC.
$110
Lilly USA, LLC
$106
Lundbeck LLC
$98
Mylan Specialty L.P.
$85
Esperion Therapeutics, Inc.
$82
Novartis Pharmaceuticals Corporation
$81
Takeda Pharmaceuticals U.S.A., Inc.
$43
Gilead Sciences, Inc.
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$41
Radius Health, Inc.
$41
Amgen Inc.
$36
Sumitomo Pharma America, Inc.
$27
GlaxoSmithKline, LLC.
$27
OWP Pharmaceuticals, Inc.
$26
Verity Pharmaceuticals Inc.
$26
Supernus Pharmaceuticals, Inc.
$21
Eisai Inc.
$16
Exact Sciences Corporation
$15
IDORSIA PHARMACEUTICALS US INC
$14
Astellas Pharma US Inc
$14
Tolmar, Inc.
$14
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,491
Novo Nordisk Inc
$2,476
Lilly USA, LLC
$1,711
ABBVIE INC.
$1,122
PFIZER INC.
$1,010
Amgen Inc.
$918
Boehringer Ingelheim Pharmaceuticals, Inc.
$836
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$638
Teva Pharmaceuticals USA, Inc.
$560
Takeda Pharmaceuticals U.S.A., Inc.
$526
Otsuka America Pharmaceutical, Inc.
$500
Amarin Pharma Inc.
$464
Astellas Pharma US Inc
$362
GlaxoSmithKline, LLC.
$304
AbbVie Inc.
$277
ARBOR PHARMACEUTICALS, INC.
$263
Merck Sharp & Dohme Corporation
$249
Kowa Pharmaceuticals America, Inc.
$230
Janssen Pharmaceuticals, Inc
$224
Bayer Healthcare Pharmaceuticals Inc.
$222
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$181
SANOFI-AVENTIS U.S. LLC
$179
Novartis Pharmaceuticals Corporation
$170
Lundbeck LLC
$152
Bayer HealthCare Pharmaceuticals Inc.
$139
Gilead Sciences, Inc.
$137
Biohaven Pharmaceuticals, Inc.
$131
Supernus Pharmaceuticals, Inc.
$125
Aytu BioScience, Inc
$116
Esperion Therapeutics, Inc.
$110
IDORSIA PHARMACEUTICALS US INC
$104
ITI, Inc.
$98
Merck Sharp & Dohme LLC
$91
Mylan Specialty L.P.
$85
Allergan Inc.
$78
Axsome Therapeutics, Inc.
$76
Radius Health, Inc.
$68
Arbor Pharmaceuticals, Inc.
$68
Eisai Inc.
$57
Bausch Health US, LLC
$54
Tolmar, Inc.
$51
Biogen, Inc.
$50
Antares Pharma, Inc.
$49
Allergan, Inc.
$49
Shire North American Group Inc
$47
Exact Sciences Corporation
$40
Medicure Pharma Inc.
$38
E.R. Squibb & Sons, L.L.C.
$35
Zyla Life Sciences
$34
AMAG Pharmaceuticals, Inc.
$33
Upsher-Smith Laboratories LLC
$32
Avanir Pharmaceuticals, Inc.
$28
Sumitomo Pharma America, Inc.
$27
OWP Pharmaceuticals, Inc.
$26
Verity Pharmaceuticals Inc.
$26
Biohaven Pharmaceutical Holding Company Ltd.
$24
Abbott Laboratories
$21
Genentech USA, Inc.
$20
Tris Pharma Inc
$17
Zyla Life Sciences, Inc.
$15
Synergy Pharmaceuticals Inc
$15
Philips Electronics North America Corporation
$13
Ironshore Pharmaceuticals Inc.
$12
Milliken Healthcare Products, LLC
$12
AbbVie, Inc.
$11
Neuronetics, Inc.
$11
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADUHELM · AIRSUPRA · AJOVY · AMYVID · APLENZIN · AREXVY · AUSTEDO · Aimovig · Amitiza · Auvelity · BASAGLAR · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · Dayvigo · Dexilant · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FASENRA · FORTEO · FREESTYLE LIBRE 2 · GEMTESA · HUMIRA · Horizant · INTRAROSA · JANUVIA · JARDIANCE · JATENZO · Jornay 100 mg capsules (Bottle of 100) · Kerendia · LEQVIO · LINZESS · LUCEMYRA · LYRICA · Leqembi · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · Myrbetriq · NEUROSTAR TMS THERAPY · NEXLETOL · NOCDURNA · NUEDEXTA · NURTEC ODT · Natesto · Otezla · Ozempic · PREMARIN · PREVNAR 13 · PREVNAR 20 · Prolia · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · Qelbree · REXULTI · RYBELSUS · Repatha · Rybelsus · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRIX · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Subvenite · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TRUMENBA · Tlando · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · YUPELRI · ZORVOLEX · ZYPITAMAG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
19
County median income
$58,388
Nearest hospital to ZIP centroid (approximate)
CHI ST JOSEPH HEALTH REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jones is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jones experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Jones performed 445 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jones receive payments from pharmaceutical companies?
Yes. Dr. Jones received a total of $18,336 from 66 companies across 1,066 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jones's costs compare to other opticians in Bryan?
Dr. Jones's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jones) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Bryan
Browse opticians in Bryan ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology